These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8347271

  • 1. Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model.
    Torras J, Bordalba JR, Seron D, Moliner R, Carrera M, Valles J, Martinez-Castelao A, Alsina J, Griño JM.
    Transpl Int; 1993; 6(4):236-8. PubMed ID: 8347271
    [Abstract] [Full Text] [Related]

  • 2. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M, Torras J, Herrero I, Valles J, Paubert-Braquet M, Cruzado JM, Alsina J, Grinyo JM.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [Abstract] [Full Text] [Related]

  • 3. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
    Liu XH, Eun BL, Silverstein FS, Barks JD.
    Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
    Droy-Lefaix MT, Drouet Y, Braquet P, Géraud G.
    Adv Exp Med Biol; 1990 Dec; 264():419-22. PubMed ID: 2244522
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A, López-Novoa JM, Arévalo M.
    Exp Nephrol; 1997 Dec; 5(1):47-54. PubMed ID: 9052848
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P.
    Prostaglandins; 1987 Sep; 34(3):337-49. PubMed ID: 3432553
    [Abstract] [Full Text] [Related]

  • 14. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
    Uluoglu C, Timlioglu O.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):324-30. PubMed ID: 10543435
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ.
    Minor T, Isselhard W.
    J Hepatol; 1993 Jul; 18(3):365-8. PubMed ID: 8228131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the platelet-activating factor receptor antagonist BN 52021 on hematologic variables and blood loss during and after cardiopulmonary bypass.
    Nathan N, Mercury P, Denizot Y, Cornu E, Laskar M, Arnoux B, Feiss P.
    Anesth Analg; 1994 Aug; 79(2):205-11. PubMed ID: 7639352
    [Abstract] [Full Text] [Related]

  • 19. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion.
    Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, Braquet P.
    Free Radic Res Commun; 1991 Aug; 12-13 Pt 2():725-35. PubMed ID: 2060844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.